Representation of metabolic pathways of lipoprotein
Representation of metabolic pathways of lipoprotein. Chylomicrons are synthesized from the intestine and are elaborated by the members of the low-density lipoprotein (LDL) receptors. Very low-density lipoprotein (VLDL)/intermediate density lipoprotein (IDL)/LDL particles are produced by the liver and the LDL clearance is due to the LDH receptors. The high-density lipoprotein (HDL) metabolic pathway involves the synthesis of discoidal HDLs and the formation of mature spherical HDLs. Their clearance is due to the action of the SR-BI receptor. The exchange of lipids between HDLs, chylomicrons, chylomicron remnants, and VLDLs is also represented. LPLs are essential for the conversion from chylomicron (CM) to CM remnants in the exogenous pathway and from VLDLs to LDLs in the endogenous pathway. Apolipoprotein C-II (APOC2) is a critical factor for LPL activity. Apolipoprotein C-III (APOC3) competes with LPL for binding to lipid emulsion particles. MTTP: microsomal triglyceride transfer protein; CEPT: cholesteryl ester transfer protein; LPL: lipoprotein lipase; PLTP: phospholipid transfer protein; ABCA1: ATP-binding cassette transporter; ApoB100: apolipoprotein B; ApoB48: apolipoprotein B48; LCAT: lecithin–cholesterol acyltransferase
Publication
Protective Effects of High-Density Lipoprotein on Cancer Risk: Focus on Multiple Myeloma (2024) Alessandro Allegra, et al. Biomedicines. 2024 Mar;12(3). Figure: F1.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | ApoA1 | APOA1 | ncbigene_symbol | APOA1 | 335 |
| Homo sapiens | Primates | HDL | HDL | ncbigene_synonym | HSD11B1 | 3290 |
| Homo sapiens | Primates | HDL | HDL | famplex_relations | ALB | 213 |
| Homo sapiens | Primates | HDL | HDL | famplex_relations | APOA2 | 336 |
| Homo sapiens | Primates | HDL | HDL | famplex_relations | APOE | 348 |
| Homo sapiens | Primates | HDL | HDL | famplex_relations | CLU | 1191 |
| Homo sapiens | Primates | LCAT | LCAT | ncbigene_symbol | LCAT | 3931 |
| Homo sapiens | Primates | ABCA1 | ABCA1 | ncbigene_symbol | ABCA1 | 19 |
| Homo sapiens | Primates | SR-B1 | SRB1 | ncbigene_synonym | SCARB1 | 949 |
| Homo sapiens | Primates | ApoB100 | APOB100 | ncbigene_synonym | APOB | 338 |
| Homo sapiens | Primates | MTTP | MTTP | ncbigene_symbol | MTTP | 4547 |
| Homo sapiens | Primates | MTTP | MTTP | ncbigene_synonym | TRNP | 4571 |
| Homo sapiens | Primates | LDLr | LDLR | ncbigene_symbol | LDLR | 3949 |
| Homo sapiens | Primates | LPL | LPL | ncbigene_symbol | LPL | 4023 |
| Homo sapiens | Primates | LPL | LPL | ncbigene_synonym | LCP1 | 3936 |
| Homo sapiens | Primates | ApoC3 | APOC3 | ncbigene_symbol | APOC3 | 345 |
| Homo sapiens | Primates | ApoC2 | APOC2 | ncbigene_symbol | APOC2 | 344 |
| Homo sapiens | Primates | PLTP | PLTP | ncbigene_symbol | PLTP | 5360 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| LDL | LDL | chebi:39026 | ||
| LDL | LDL | chebi:39026 | ||
| VLDL | VLDL | chebi:39027 | ||
| IDL | IDL | chebi:132933 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|